OxyDial has developed a next-generation blood testing instrument for measuring the Oxygen-hemoglobin Dissociation Curve and other blood parameters. Designed to reduce the daily struggle of Sickle Cell Disease and other blood disorders, our purpose-built instrument is portable, fast, precise, simple to operate, and requires only a drop of blood.
OxyDial aims to radically streamline pharma R&D, Clinical, Chronic, and Emergency Medical Care - helping improve outcomes for patients worldwide.